Vikram Vohra

New Delhi, DL, India

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 19 publications

Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).

Efficacy and safety of VPM1002 and Immuvac in preventing tuberculosis: phase 3 randomised clinical trial (PreVenTB trial).

Journal: BMJ (Clinical research ed.)

Published: April 10, 2026

Authors' Response.

Authors' Response.

Journal: The Indian journal of medical research

Published: April 06, 2026

Artificial intelligence (AI)-driven ensemble model for comprehensive chest X-ray abnormality detection and deployment.

Artificial intelligence (AI)-driven ensemble model for comprehensive chest X-ray abnormality detection and deployment.

Journal: The Indian journal of medical research

Published: July 15, 2025

Clinico-demographic profile of pre-extensively drug-resistant pulmonary tuberculosis patients in India.

Clinico-demographic profile of pre-extensively drug-resistant pulmonary tuberculosis patients in India.

Journal: The Indian journal of tuberculosis

Published: February 17, 2025

Four-month clofazimine regimen for susceptible pulmonary TB: a randomized clinical trial.

Four-month clofazimine regimen for susceptible pulmonary TB: a randomized clinical trial.

Journal: The Journal of antimicrobial chemotherapy

Published: February 13, 2025

Association of treatment interruption with sputum conversion and outcomes in drug-sensitive and drug-resistant tuberculosis patients enrolled under NTEP-a prospective study from 3 centers in South Delhi, Delhi, India.

Association of treatment interruption with sputum conversion and outcomes in drug-sensitive and drug-resistant tuberculosis patients enrolled under NTEP-a prospective study from 3 centers in South Delhi, Delhi, India.

Journal: The Indian journal of tuberculosis

Published: August 28, 2024

Effect of Bedaquiline and Delamanid Pharmacokinetics on Sputum Culture Conversion and Adverse Events in Drug-Resistant Tuberculosis.

Effect of Bedaquiline and Delamanid Pharmacokinetics on Sputum Culture Conversion and Adverse Events in Drug-Resistant Tuberculosis.

Journal: Therapeutic drug monitoring

Published: July 20, 2023

Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis.

Linezolid Pharmacokinetics and Its Association with Adverse Drug Reactions in Patients with Drug-Resistant Pulmonary Tuberculosis.

Journal: Antibiotics (Basel, Switzerland)

Published: February 19, 2023

Risk factors of treatment interruptions among drug-sensitive and drug-resistant pulmonary tuberculosis patients - A study from South Delhi, New Delhi, India.

Risk factors of treatment interruptions among drug-sensitive and drug-resistant pulmonary tuberculosis patients - A study from South Delhi, New Delhi, India.

Journal: The Indian journal of tuberculosis

Published: November 03, 2022

Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.

Bedaquiline, Delamanid, Linezolid and Clofazimine for Treatment of Pre-extensively Drug-Resistant Tuberculosis.

Journal: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Published: February 26, 2022

To study the impact of active case finding (ACF) among the TB patients detected in South Delhi.

To study the impact of active case finding (ACF) among the TB patients detected in South Delhi.

Journal: The Indian journal of tuberculosis

Published: June 16, 2020

Association of Tuberculosis With Household Catastrophic Expenditure in South India.

Association of Tuberculosis With Household Catastrophic Expenditure in South India.

Journal: JAMA network open

Published: February 13, 2020

Showing 1-12 of 19

Last Updated: 09/26/2026